Physical Pharmacy and Formulation
A section of Pharmaceutics (ISSN 1999-4923).
Section Information
This section is intended to rapidly publish all aspects of current issues in physicochemical characterization of drug substances including proteins, and their formulation design and products development. An example of specific topics includes but not limited to:
Physical Pharmacy
- Solubility
- Solubilization
- Dissolution
- Polymorphism
- Permeability
- Stability and stabilization
- New materials for controlling drug characteristics
- Analytical techniques
Formulation
- Novel excipients
- Formulation science
- Drug delivery systems
- Controlled release
- Drug targeting
- Bioavailability
- Quality-by-design
- Regulatory science
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Alzheimer's Disease: An Update on Novel Therapeutics (Deadline: 20 June 2023)
- Dry Powder Inhalers (Deadline: 20 June 2023)
- Advances in Pickering-Emulsion-Based Drug Delivery Systems (Deadline: 30 June 2023)
- Principles, Limitations, and Recent Progress in 3D Printing for Pharmaceutical Applications (Deadline: 30 June 2023)
- Recent Advances in Drugs and Prodrugs Design in the Field of Infectious Diseases (Deadline: 30 June 2023)
- Advances in Pharmaceutical Solid Forms (Deadline: 30 June 2023)
- Amorphous Drug Formulations: Progress, Challenges and Perspectives (Deadline: 30 June 2023)
- Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages (Deadline: 10 July 2023)
- Recent Advances in Pharmaceutical Dosage Forms (Deadline: 20 July 2023)
- Controlled Crystallization of Active Pharmaceutical Ingredients, 2nd Edition (Deadline: 20 July 2023)
- New Perspectives for the Administration of Cannabis for Medical Use: From Traditional to Advanced Formulations. What Next? (Deadline: 20 July 2023)
- Formulation of Poorly Water-Soluble Drugs (Deadline: 20 July 2023)
- Drug Polymorphism and Dosage Form Design (Volume II) (Deadline: 30 July 2023)
- Recent Non-oral Dosage Form Development: Focus on 3D-Printed Formulations (Deadline: 30 July 2023)
- Advance in Development of Patient-Centric Dosage Form, 2nd Edition (Deadline: 31 July 2023)
- Orally Disintegrating Dosage Forms Based on Cyclodextrins and Hydrophilic Polymers (Deadline: 31 July 2023)
- Biopolymers for Biomedical and Pharmaceutical Applications (Deadline: 31 July 2023)
- Research on New Crystal Forms of Antitumor Drugs: Development and Controlled Release (Deadline: 31 July 2023)
- Essential Oil in Pharmaceutical Products for the Management of Chronic Diseases (Deadline: 31 July 2023)
- Research and Development of Novel MOFs (Metal-Organic Framework) Drug Formulations (Deadline: 31 July 2023)
- HIV/AIDS Prevention Formulation Design and Optimization and Its Pharmacokinetic-Pharmacodynamic Evaluation (Deadline: 31 July 2023)
- Functional Polymeric Materials for Drug Delivery and Sustained Drug Release (Deadline: 10 August 2023)
- Pharmaceutical Solid Forms: From Crystal Structure to Formulation (Deadline: 20 August 2023)
- Advanced Spray Drying Technology in Pharmaceutical Formulations: Novel Applications Using Polymeric and Lipidic Excipients (Deadline: 20 August 2023)
- Antimicrobial Agents Based on Nanomaterials (Deadline: 20 August 2023)
- Non-invasive Biopharmaceutical/Vaccine Delivery Systems and Formulation Strategies (Deadline: 20 August 2023)
- Advances in Pharmaceutical Nanocrystals (Deadline: 20 August 2023)
- Global Paediatric Drug Development (Deadline: 31 August 2023)
- Quality by Design in Pharmaceuticals (Deadline: 31 August 2023)
- Strategies for Enhancing the Bioavailability of Poorly Soluble Drugs, 2nd Edition (Deadline: 20 September 2023)
- Drugs-Excipients Interactions (Deadline: 20 September 2023)
- Pharmaceutical Manufacturing Process of Inhaled Drugs (Deadline: 25 September 2023)
- Polymorphism (Deadline: 30 September 2023)
- The Latest Development of Multifunctional Nanopharmaceutical Formulations and Its Application (Deadline: 30 September 2023)
- Essential Oils in Pharmaceutical Products (Volume II) (Deadline: 30 September 2023)
- Machine Learning for Dosage Forms Developments (Deadline: 30 September 2023)
- Advances in Natural Products for Cutaneous Application (Deadline: 15 October 2023)
- Oxidative Stress and Inflammation: Novel Drug Formulation and Delivery Systems (Deadline: 20 October 2023)
- Advances in Amorphous Drug Formulations, Volume II (Deadline: 31 October 2023)
- Formulation and Delivery of Traditional Medicines and Natural Products (Deadline: 31 October 2023)
- Semisolid Dosage (Volume III) (Deadline: 31 October 2023)
- Polymorphism and Pseudopolymorphism of Pharmaceutical Substances (Deadline: 31 October 2023)
- Stability and Formulation of Drug Substances and Pharmaceutical Products (Deadline: 31 October 2023)
- Hybrid Materials and Their Applications in the Pharmaceutical or Medical Field (Deadline: 1 November 2023)
- Multicomponent Solid Forms as Modifying Agents for Drugs with Solubility Problems (Deadline: 30 November 2023)
- New Trends in the Controlled Release Systems of Medicinal Substances Used in the Treatment of Diseases of the Central Nervous System (Deadline: 20 December 2023)
- Research on the Prediction and Optimization of the Solubility and Permeability of Biopharmaceuticals (Deadline: 20 December 2023)
- Cell and Tissue-Based Formulations: from Design to Biomedical Applications (Deadline: 31 December 2023)
- Advanced Pharmaceutical Science and Technology in Germany (Deadline: 31 December 2023)
- Biomedical Applications of Topical Formulations for Skin and Mucosal Disorders (Deadline: 15 April 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
